Total assets · 2016–2025
Ascendis Pharma total assets
$1.5B+24.9% · FY2025
Ascendis Pharma (ASND) reported $1.5B in total assets for fiscal 2025, +24.9% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.5B | +24.9% | Open → |
| FY20242024-12-31 | $1.2B | +34.3% | Open → |
| FY20232023-12-31 | $912M | −21.5% | Open → |
| FY20222022-12-31 | $1.2B | −5.4% | Open → |
| FY20212021-12-31 | $1.2B | +2.2% | Open → |
| FY20202020-12-31 | $1.2B | +58.1% | Open → |
| FY20192019-12-31 | $760M | +108.2% | Open → |
| FY20182018-12-31 | $365M | +44.3% | Open → |
| FY20172017-12-31 | $253M | +26.3% | Open → |
| FY20162016-12-31 | $200M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +25.3%
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ascendis Pharma total assets |url=https://companiesranked.com/en/company/ascendis-pharma/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ascendis Pharma total assets. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/total-assetsBibTeX
@misc{companiesranked-en-company-ascendis-pharma-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Ascendis Pharma total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026
{{cite web |title=Ascendis Pharma total assets — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.